Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-643-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015-07-24 to 2015-09-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- The Measurements of the cell proliferation by cell counting instead of radioactive labelling. Measurement of the ear swelling after treatment was done with Oditest S0277 on the first and last test day and mass determination of circular ear punches.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: Ehling, G., M. Hecht, A. Heusener, J. Huesler, A. O. Gamer, H. van Loveren, T. Maurer, K. Riecke, L. Ullmann, P. Ulrich, R. Vandebriel, H.-W. Vohr: An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay. 1st
- Deviations:
- yes
- Remarks:
- The Measurements of the cell proliferation by cell counting instead of radioactive labelling. Measurement of the ear swelling after treatment was done with Oditest S0277 on the first and last test day and mass determination of circular ear punches.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- Ehling, G., M. Hecht, A. Heusener, J. Huesler, A. O. Gamer, H. van Loveren, T. Maurer, K. Riecke, L. Ullmann, P. Ulrich, R. Vandebriel, H.-W. Vohr: An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay. 2nd
- Deviations:
- yes
- Remarks:
- The Measurements of the cell proliferation by cell counting instead of radioactive labelling. Measurement of the ear swelling after treatment was done with Oditest S0277 on the first and last test day and mass determination of circular ear punches.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH; Sandhofer Weg 7, D-97633 Sulzfeld
- Age at study initiation: 62 days
- Weight at study initiation: 29 - 36 g
- Housing: MAKROLON cages (type II)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 °C +/- 3 °C
- Humidity (%): 55 % +/- 15 %
- Air changes (per hr): 12 - 18
- Photoperiod (hrs dark / hrs light): 12 h dark, 12 h light
IN-LIFE DATES: From: 2015-09-03 To: 2015-09-11 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25 µL L174: 10%, (w/w), 25%, (w/w), 50%, (w/w)
- No. of animals per dose:
- 6
- Details on study design:
- RANGE FINDING TESTS:
A preliminary experiment was carried out in 3 animals to examine the irritating potential and handling/application of the test item in order to select the appropriate concentrations. Three concentrations of 10%, 25% and 50% suspended in acetone/olive oil (4:1 v/v) were examined.
The preliminary experiment was conducted under conditions identical to the main LLNA study, except there was no assessment of lymph node proliferation and only 1 animal per concentration was used.
MAIN STUDY
Five (5) groups of 6 female animals each were examined. At the start of the experiment the mice were weighed and assigned to each of the 5 groups by a randomisation program (block size n = 6).
Group Concentration and application volume per ear Number of animals Animal no.
1 5 µL vehicle (negative control) 6 1 - 6
2 25 µL L174 (10%, w/w) 6 7 - 12
3 25 µL L174 (25%, w/w) 6 13 - 18
4 25 µL L174 (50%, w/w) 6 19 - 24
5 5 µL of a 20% solution of 6 25 - 30
alpha-hexyl cinnamic aldehyde in
acetone / olive oil (4:1, v/v)
All animals were females.
The study was performed according to OECD 429, however not employing the use of radioactive labelling to measure cell proliferation, as the radioactive method proposed by the OECD guideline led to problems in various EU laboratories. However, the OECD guideline allows other endpoints for assessment of proliferation in form of lymph node cell counts and lymph node weights if justification and appropriate scientific support exist showing the validity of this method.
The alternative method used for the study employing the lymph node weight and lymph node cell count to assess proliferation has been established by an European interlaboratory validation exercise, as described in the two publications by Ehling et al. 2005a and 2005b.
In addition, the acute inflammatory skin reaction is measured by ear weight determination of circular biopsies of the ears and ear thickness measurements on test day 1 and test day 4 to identify skin irritation properties of the test item.
The experimental schedule of the assay was as follows:
-Day 1:
The weight of each animal was individually identified and recorded. In addition, ear swelling measurements were carried out at the helical edge of both ears using an Oditest micrometer.
Open application of 25 µL of the appropriate dilution of the test item, the vehicle alone or the positive control (as appropriate) were administered to the dorsum of each ear.
- Days 2 and 3:
The application procedure carried out on day 1 was repeated
- Day 4 (24 hours after the last application):
Ear swelling measurements (immediately before sacrificing the mice) were carried out at the helical edge of both ears using an Oditest micrometer.
The animals were sacrificed under ether anaesthesia. Punch biopsies of 8 mm in diameter of the apical area of both ears were prepared and immediately weighed on an analytical balance.
Lateral pairs of auricular lymph nodes draining the ear tissue were excised, carefully separated from remaining fatty tissue and weighed on an analytical balance immediately following preparation. The lymph nodes were then stored on ice in PBS /0.5% BSA and subjected to the preparation of single cell suspensions by mechanical tissue disaggregation. The cells were counted automatically in a cell counter. - Statistics:
- U-test according to Mann and Whitney (lymph node weight significance; cell count).
Linear regression analysis employing Person's correlation coefficient (possible concentration-response-relationship for the lymph node weight).
Nalimov test (determination of outliners).
Standard deviation and relative standard deviation were calculated, too. - Positive control results:
- Parameter stimulation indices (SI)
group 5, positive control
Lymph node cell count 1.676
Lymph node weight 1.326
Ear weight 1.133
Ear thickness, TD4 1.096 - Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- Main study results: stimulation indices (SI): Parameter Group 1, Group 2, Group 3, Group 4, Group 5 neg. control 10 % 25 % 50 % pos. control Lymph node cell count 1.000 0.887 0.982 1.113 1.676 Lymph node weight 1.000 1.043 1.087 1.065 1.326 Ear weight 1.000 0.963 0.989 0.968 1.133 Ear thickness, TD4 1.000 1.026 1.026 1.000 1.096 ____ significantly different from control at p ≤ 0.01
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the present test conditions, L174 at concentrations of 10%, 25% or 50% (w/w) in acetone/olive oil (4:1, v/v) did not reveal any sensitising properties in the local lymph node assay.
- Executive summary:
The purpose of this study was to determine the sensitising potential of L174 in the modified local lymph node assay in mice.
The study was performed according to OECD 429, however not employing the use of radioactive labelling to measure cell proliferation, as the radioactive method proposed by the OECD guideline led to problems in various EU laboratories: such as (i) practical difficulties/complexity of the test, in particular the radiochemical steps, which sometimes resulted in loss of specimen/activity; this in turn led to variability in the results and to a poor reproducibility and (ii) radiation protection issues. However, the OECD guideline allows other endpoints for assessment of proliferation in form of lymph node cell counts and lymph node weights if justification and appropriate scientific support exist showing the validity of this method.
The alternative method used for the study employing the lymph node weight and lymph node cell count to assess proliferation has been established by an European interlaboratory validation exercise, as described in the two publications by Ehling et al. 2005a and 2005b.This method has the advantage of (i) more simplistic experimental work, (ii) less variability, (iii) better reproducibility, (iv) faster results, (v) reduced costs.
In addition, the acute inflammatory skin reaction is measured by ear weight determination of circular biopsies of the ears and ear thickness measurements on test day 1 and test day 4 to identify skin irritation properties of the test item. It is important to determine if a positive test result is due to the skin irritation potential of the test item or due to its sensitising properties.
Stimulation indices were calculated for the lymph node cell count, lymph node weight, ear weight and ear thickness by dividing the average values per group of the test item treated animals by the vehicle treated ones.
Values above 1.4 (lymph node cell count to identify sensitisation) or 1.1 (ear weight to identify irritation) are considered positive (these values were fixed empirically during the interlaboratory validation of this method (Ehling et al. 2005a and 2005b)).
Three concentrations of L174 (10%, 25% and 50% (w/w), suspended in acetone/olive oil (4:1, v/v))(w/w) were tested in six female NMRI mice per group and compared to a vehicle control group.
A 50% suspension was the highest feasible concentration of L174 in acetone/olive oil (4:1, v/v).
In addition, a positive control group (20% solution v/v of alpha-hexyl cinnamic aldehyde in acetone/olive oil (4:1, v/v)) was employed.
Stimulation indices (SI):
Parameter
Group 1, negative control
Group 2,
10%
Group 3, 25%
Group 4, 50%
Group 5,
positive control
Lymph node cell count
1.000
0.887
0.982
1.113
1.676
Lymph node weight
1.000
1.043
1.087
1.065
1.326
Ear weight
1.000
0.963
0.989
0.968
1.133
Ear thickness, TD4
1.000
1.026
1.026
1.000
1.096
____ significantly different from control at p ≤ 0.01
In the main study treatment with L174 at concentrations of 10%, 25% or 50% did not reveal any statistical significantly increased values for the lymph node cell count. The stimulation indices of the lymph node cell count did not exceed the threshold level of 1.4. In addition, no significant increase in the lymph node weight was observed. Hence, the test item is classified as not sensitising.
The threshold level for the ear weight of 1.1 was not exceeded and no increase of ear thickness was observed, i.e. no irritating properties were noted.
The positive control group caused the expected increases in lymph node cell count and lymph node weight (statistically significant at p ≤ 0.01).Therefore, the study can be regarded as valid.
No signs of local or systemic intolerance were recorded. The animal body weight was not affected by the treatment.
In conclusion, under the present test conditions, L174 at concentrations of 10%, 25% or 50% (w/w) in acetone/olive oil (4:1, v/v) did not reveal any sensitising properties in the local lymph node assay.
Reference
No signs of local or systemic intolerance were recorded.
The animal body weight was not affected by the treatment.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The variation L174 was tested for its skin sensitising potential. L174 did not reveal any sensitising properties in the local lymph node assay (modified).
The same sensitising profile is expected for other variations of the substance lutetium aluminium oxide, cerium doped, garnet.
Migrated from Short description of key information:
The variation L174 was tested for its skin sensitising potential. L174 did not reveal any sensitising properties in the local lymph node assay (modified). The same sensitising profile is expected for other variations of the substance lutetium aluminium oxide, cerium doped, garnet.
Justification for selection of skin sensitisation endpoint:
Available GLP guideline study
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Lutetium aluminium oxide, cerium doped, garnet did not show any potential to cause skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.